ALEXANDRIA, Va., July 9 -- United States Patent no. 12,350,298, issued on July 8, was assigned to Finch Therapeutics Holdings LLC (Boston).
"Microbiome related immunotherapies" was invented by Joseph Lobacki (Somerville, Mass.), Ulrich Thienel (Somerville, Mass.), Zain Kassam (Somerville, Mass.) and Marina Santiago (Somerville, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention generally relates to therapeutic compositions and methods for treating cancer patients. The compositions and methods can increase efficacy of an anti-cancer therapy, or treat, prevent, or inhibit an oncology-treatment induced condition (OTIC) induced by an anti-cancer therapy. The therapeutic compositions compr...